Louben Dorval

Preclinical Scientist at Akero Therapeutics - South San Francisco, CA, US

Louben Dorval's Colleagues at Akero Therapeutics
John CEP

Vice President Finance and Controller

Contact John CEP

Kitty Yale

EVP and Chief Development Officer

Contact Kitty Yale

Brittany De Temple

director of clinical operations and program management

Contact Brittany De Temple

Yuan Xu

Independent Board Director

Contact Yuan Xu

Kimberly Barrett

Associate Director, Clinical Data Management

Contact Kimberly Barrett

View All Louben Dorval's Colleagues
Louben Dorval's Contact Details
HQ
650-487-6488
Location
Greater Boston
Company
Akero Therapeutics
Louben Dorval's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Louben Dorval
Louben Dorval currently works for Akero Therapeutics.
Louben Dorval's role at Akero Therapeutics is Preclinical Scientist.
Louben Dorval's email address is ***@akerotx.com. To view Louben Dorval's full email address, please signup to ConnectPlex.
Louben Dorval works in the BioTech/Drugs industry.
Louben Dorval's colleagues at Akero Therapeutics are John CEP, Yasmine CPA, Kitty Yale, Brittany De Temple, Yuan Xu, Kimberly Barrett, Whitney Withington and others.
Louben Dorval's phone number is 650-487-6488
See more information about Louben Dorval